Trauma InjurySGINHZAGNCT06623825
Smart Glasses in Emergency Medicine From the Hangzhou Asian Games
An observational study of Trauma Injury and Acute Coronary Syndrome, run by Sir Run Run Shaw Hospital at 1 site in China.
Trial summary
The findings of our study will reveal that using smart glasses in the emergency department(ED) could facilitate patient admission. AR Smart Glasses offer the potential to enhance the effectiveness and speed of treatment within ED. Read more about this study
- Who is it for?
- Ages 16 years and older
- Conditions the study is for
- Trauma Injury, Acute Coronary Syndrome, Stroke, Acute
- What is being tested?
- teleconsultation by Augmented Reality smart glasses and teleconsultation by two-way radio connection.
- Type of treatment
- Medical device
- How many people
- 90 participants
- Where
- 1 siteChina
- Study dates
- 27 Sep 2023to 20 Nov 2023
- How long will I take part?
- 2 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Following the completion of the research period, there will be 80 patients categorized into the ARTS cohort consisting of 10 patients and the non-ARTS cohort comprising 70 patients. Gender and age demographics for ARTS and non-ARTS cohorts will be shown with no significant gender differences.
Who may be able to join
- Presenting with acute illnesses like acute coronary syndrome，acute sepsis，stroke，trauma who will be admitted to the ED of SRRSH from the HAG2022 village polyclinic or the field of injury.
Who cannot join
- The Cases with incomplete data and cases where the patients will be not found will be excluded from this study. Cases involving technical difficulties encountered by operators using augmented reality (AR) smart glasses and loss of internet connection will be excluded from the study.
Trial locations and contacts
1 site in 1 country.
China1 site
Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310012
About this study
Official title: Evaluating the Efficiency of Smart Glasses in Reducing Patient Care Time in Emergency Medicine: Evidence From the Hangzhou Asian Games
The findings of our study will reveal that using smart glasses in the emergency department(ED) could facilitate patient admission. AR Smart Glasses offer the potential to enhance the effectiveness and speed of treatment within ED.
Read the detailed description
Study Design:
This study will be conducted at Sir Run Run Shaw Hospital (SRRSH), China. This study aims to compare the outcomes of two groups: the intervention group, utilizing the Augmented Reality (AR) smart glasses, and the control group, adhering to the standard conventional triage process without the AR tool, only using a two-way radio connection.
Augmented Reality tool The AR tool used in this study will be a smart glasses manufactured by Rokid AR Studio(Hangzhou, China). It was Rokid glass 2 model released in 2020. The device operated on Android 9.0 and it connected to 5G connection with a bandwidth speed 30-mbps delivering a very low latency. The device supported real time screen sharing and therefore the data were collected from smart glasses including visual and audio with real-time two-way communications. Physicians at the hospital can access the information and video via a mobile app, enabling continuous monitoring of patients. The features facilitate healthcare providers at SRRSH and medical personnel in the HAG2022 polyclinic to discuss the patient's condition, exchange, and deliberate on the pre-hospital medical examinations of the patient.
Participants:
The study, will be conducted between September 13, 2023, and October 28, 2023, included the recruitment of all patients (older than 16 years old) presenting with acute illnesses who were admitted to the ED of SRRSH from the HAG2022 village polyclinic or the field of injury.
The Cases with incomplete data and cases where the patients would be not found will be excluded from this study. Cases involving technical difficulties encountered by operators using augmented reality (AR) smart glasses and loss of internet connection will be excluded from the study.
- Conditions
- Trauma Injury, Acute Coronary Syndrome, Stroke, Acute, Septic Shock
- Being tested
- teleconsultation by Augmented Reality smart glasses, teleconsultation by two-way radio connection.
- Keywords
- Telemedicine, Tele-consultation, Smart glasses, Emergency Medicine
- Medical subject headings
- Accidental Injuries, Acute Coronary Syndrome, Stroke, Shock, Septic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
teleconsultation by Augmented Reality smart glassesDevice
Also called realtime teleconsultation by Augmented Reality smart glasses
The device operated on Android 9.0 and it connected to 5G connection with a bandwidth speed 30-mbps delivering a very low latency. The device supported real time screen sharing and therefore the data were collected from smart glasses including visual and audio with real-time two-way communications. Physicians at the hospital can access the information and video via a mobile app, enabling continuous monitoring of patients. The features facilitate healthcare providers at SRRSH and medical personnel in the HAG2022 polyclinic to discuss the patient's condition, exchange, and deliberate on the pre-hospital medical examinations of the patient.
teleconsultation by two-way radio connection.Device
Also called the traditional teleconsultation by two-way radio connection.
adhering to the standard conventional triage process without the AR tool, only using a two-way radio connection.
| Study group | Role | What they receive |
|---|---|---|
| ARTS | the teleconsultation by AR telemedicine system group Receives: Device: teleconsultation by Augmented Reality smart glasses | |
| non-ARTS | no teleconsultation by AR telemedicine system groups,but by the traditional methods like radios, telephonecalls Receives: Device: teleconsultation by two-way radio connection. |
What is being measured
The primary outcome is the main question the study is designed to answer.
the consult response time (CRT)
CRT refers to the duration from when consulting physicians are called to evaluate patients in the ED to their response
Measured: through study completion, an average of 1 year
pre-preparation time (PPT )
PPT refers to the duration required to prepare the patient for subsequent management
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2024
- Study start27 Sep 2023
- Primary completion30 Oct 2023
- Study completion20 Nov 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Trauma InjuryStudies of the same condition, open and under way.
- More trials run by Sir Run Run Shaw HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 90 participants (actual)
- Target duration
- 2 Months
Sponsor and investigators
- Lead sponsor
- Sir Run Run Shaw Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yucai Hong, Sir Run Run Shaw Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06623825
- Sponsor's protocol ID
- v1.020230801
- Acronym
- SGINHZAG
- Status last verified
- Sep 2024
- First submitted
- 14 Sep 2024
- Last updated
- 2 Oct 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Jiang X, Xia B, Ansari MM, Jiang H, Qi J, Zhang Z, Dai S, Zheng P, He Y, Liu N, Chen P, Luo R, Qin X, Miao Y, Dai J, Zhou X, Wang C, Chen H, Xu W, Wu T, Shi Q, Chen Z, Zhou L, Zhang H, Xie Y, Zhang Q, Zhou B, Pan X, Chen Z, Zhen L, Sun Y, Lu Z, Loh Y, Sayer S, Mochtar J, Wongpraewit P, Wang Y, Hong Y. Evaluating the Effectiveness of Smart Glasses in Reducing Patient Care Time in Emergency Departments: Cohort Study From the Hangzhou Asian Games. JMIR Form Res. 2025 Jun 30;9:e65617. doi: 10.2196/65617.
PubMed 40587811
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating the Efficiency of Smart Glasses in Reducing Patient Care Time in Emergency Medicine: Evidence From the Hangzhou Asian Games
- ClinicalTrials.gov ID
- NCT06623825
- Acronym / sponsor ID
- SGINHZAG / v1.020230801
- Conditions
- Trauma Injury, Acute Coronary Syndrome, Stroke, Acute, Septic Shock
- Keywords
- Telemedicine, Tele-consultation, Smart glasses, Emergency Medicine
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Sir Run Run Shaw HospitalUniversity, hospital or other
- Study start
- 27 Sep 2023 (actual)
- Primary completion
- 30 Oct 2023 (actual)
- Study completion
- 20 Nov 2023 (actual)
- First posted
- 2 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The findings of our study will reveal that using smart glasses in the emergency department(ED) could facilitate patient admission. AR Smart Glasses offer the potential to enhance the effectiveness and speed of treatment within ED.
Detailed description
Study Design:
This study will be conducted at Sir Run Run Shaw Hospital (SRRSH), China. This study aims to compare the outcomes of two groups: the intervention group, utilizing the Augmented Reality (AR) smart glasses, and the control group, adhering to the standard conventional triage process without the AR tool, only using a two-way radio connection.
Augmented Reality tool The AR tool used in this study will be a smart glasses manufactured by Rokid AR Studio(Hangzhou, China). It was Rokid glass 2 model released in 2020. The device operated on Android 9.0 and it connected to 5G connection with a bandwidth speed 30-mbps delivering a very low latency. The device supported real time screen sharing and therefore the data were collected from smart glasses including visual and audio with real-time two-way communications. Physicians at the hospital can access the information and video via a mobile app, enabling continuous monitoring of patients. The features facilitate healthcare providers at SRRSH and medical personnel in the HAG2022 polyclinic to discuss the patient's condition, exchange, and deliberate on the pre-hospital medical examinations of the patient.
Participants:
The study, will be conducted between September 13, 2023, and October 28, 2023, included the recruitment of all patients (older than 16 years old) presenting with acute illnesses who were admitted to the ED of SRRSH from the HAG2022 village polyclinic or the field of injury.
The Cases with incomplete data and cases where the patients would be not found will be excluded from this study. Cases involving technical difficulties encountered by operators using augmented reality (AR) smart glasses and loss of internet connection will be excluded from the study.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Months
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ARTS | – | Device: teleconsultation by Augmented Reality smart glassesthe teleconsultation by AR telemedicine system group |
| non-ARTS | – | Device: teleconsultation by two-way radio connection.no teleconsultation by AR telemedicine system groups,but by the traditional methods like radios, telephonecalls |
Who may qualify
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Following the completion of the research period, there will be 80 patients categorized into the ARTS cohort consisting of 10 patients and the non-ARTS cohort comprising 70 patients. Gender and age demographics for ARTS and non-ARTS cohorts will be shown with no significant gender differences.
Key inclusion criteria (1 listed)
- Presenting with acute illnesses like acute coronary syndrome，acute sepsis，stroke，trauma who will be admitted to the ED of SRRSH from the HAG2022 village polyclinic or the field of injury.
Key exclusion criteria (1 listed)
- The Cases with incomplete data and cases where the patients will be not found will be excluded from this study. Cases involving technical difficulties encountered by operators using augmented reality (AR) smart glasses and loss of internet connection will be excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| teleconsultation by Augmented Reality smart glassesAlso: realtime teleconsultation by Augmented Reality smart glassesThe device operated on Android 9.0 and it connected to 5G connection with a bandwidth speed 30-mbps delivering a very low latency. The device supported real time screen sharing and therefore the data were collected from smart glasses including visual and audio with real-time two-way communications. Physicians at the hospital can access the information and video via a mobile app, enabling continuous monitoring of patients. The features facilitate healthcare providers at SRRSH and medical personnel in the HAG2022 polyclinic to discuss the patient's condition, exchange, and deliberate on the pre-hospital medical examinations of the patient. | Device | ARTS |
| teleconsultation by two-way radio connection.Also: the traditional teleconsultation by two-way radio connection.adhering to the standard conventional triage process without the AR tool, only using a two-way radio connection. | Device | non-ARTS |
Primary outcome
the consult response time (CRT)
Time frame: through study completion, an average of 1 year
CRT refers to the duration from when consulting physicians are called to evaluate patients in the ED to their response
pre-preparation time (PPT )
Time frame: through study completion, an average of 1 year
PPT refers to the duration required to prepare the patient for subsequent management
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2024.
- Derived from this study: PubMed 40587811Jiang X, Xia B, Ansari MM, Jiang H, Qi J, Zhang Z, Dai S, Zheng P, He Y, Liu N, Chen P, Luo R, Qin X, Miao Y, Dai J, Zhou X, Wang C, Chen H, Xu W, Wu T, Shi Q, Chen Z, Zhou L, Zhang H, Xie Y, Zhang Q, Zhou B, Pan X, Chen Z, Zhen L, Sun Y, Lu Z, Loh Y, Sayer S, Mochtar J, Wongpraewit P, Wang Y, Hong Y. Evaluating the Effectiveness of Smart Glasses in Reducing Patient Care Time in Emergency Departments: Cohort Study From the Hangzhou Asian Games. JMIR Form Res. 2025 Jun 30;9:e65617. doi: 10.2196/65617.
- Individual participant dataSharing planned: No
Related trials for Trauma Injury
Recruiting
NightWare and Cardiovascular Health in Women With PTSD
Post Traumatic Stress Disorder, Cardiovascular Diseases
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Active, not recruiting
CT for Personalized Mechanical Ventilation
Ventilator-Induced Lung Injury, Sepsis Syndrome
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Trauma Injury and Acute Coronary Syndrome, run by Sir Run Run Shaw Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the consult response time (CRT) (time frame: through study completion, an average of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06623825, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2024.